The Moyamoya Disease Market region demonstrates substantial geographic heterogeneity reflecting epidemiological differences, healthcare system capabilities, and cultural factors influencing disease recognition and treatment access. Asia-Pacific region dominates market share given significantly higher disease prevalence in Japan, South Korea, and China where genetic...